IMAB On Watch, GTH Expects 2022 Revenue To Grow 10-20%, PHVS To Report HAE Trial Data In Q4

SomaLogic Inc. (SLGC), a commercial-stage AI-data driven proteomics technology company, expects revenue for 2022 to grow 29% to 35% over the prior year. For full year 2022, the company expects revenue to range between $105 million and $110 million, which represents 29% to 35% growth over last year. Revenue for the full year 2021 was $81.6 million.

from RTT - Top Story https://ift.tt/l2hGzef
via IFTTT